ATP12A and gastroesophageal reflux disease: Ilaprazole, a proton pump inhibitor, has been approved and marketed in Koreaand China for the treatment of gastric ulcer, duodenal ulcer,gastroesophageal reflux disease, and erosive esophagitis.